Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
10:46am, Thursday, 02'nd Oct 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
10:37am, Wednesday, 24'th Sep 2025
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. GE, RMD, VRT and NFG are some such stocks.
ResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript
11:53am, Tuesday, 23'rd Sep 2025
ResMed Inc. (NYSE:RMD ) Bank of America Global Healthcare Conference 2025 September 23, 2025 8:20 AM EDT Company Participants Michael Farrell - CEO & Chairman Carlos Nunez - Chief Medical Officer Conf
Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
04:05pm, Tuesday, 16'th Sep 2025
SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present
Here's Why ResMed (RMD) is a Strong Growth Stock
10:45am, Friday, 12'th Sep 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The sleep economy is 'having a moment', says medical equipment firm Resmed
09:00pm, Monday, 08'th Sep 2025
Carlos Nunez, Chief Medical Officer of Resmed takes about the opportunities and challenges in the sleep economy with CNBC's Martin Soong. He joins 'Squawk Box Asia' on the sidelines of the World Sleep
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
04:15pm, Wednesday, 03'rd Sep 2025
New global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health care New global clinical insights initiative debuts at World Sleep Congress 2025 to
Is it Worth Retaining ResMed Stock in Your Portfolio Now?
09:56am, Wednesday, 03'rd Sep 2025
RMD's Mask and Device sales fuel growth, but macro headwinds and fierce competition continue to challenge its performance.
Here's Why ResMed (RMD) is a Strong Growth Stock
10:45am, Wednesday, 27'th Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
09:00am, Wednesday, 27'th Aug 2025
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the public
ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows
07:43am, Wednesday, 27'th Aug 2025
For my first rating of ResMed, I'm calling a buy, agreeing with today's consensus from Wall St. and more confident than the quant system, which said hold. Key upside factors are new business acquisiti
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
04:15pm, Monday, 18'th Aug 2025
SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15, 2025. The company also ann
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term
10:51am, Wednesday, 13'th Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
10:46am, Monday, 11'th Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings
02:16pm, Friday, 01'st Aug 2025
Resmed Inc RMD reported better-than-expected earnings for the second quarter on Thursday.
